Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review

Fig. 2

PROMs used as predictors in prognostic factor analyses and prognostic models (n = 33). More than one PROMs could be used in an analysis or model. EORTC QLQ-C30, The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire – Core 30; EORTC QLQ-LC13, EORTC Quality of Life Questionnaire–Lung Cancer Module; SF-36, 36-item Short Form Health Survey; FACT-L, Functional Assessment of Cancer Therapy–Lung; HADS, Hospital Anxiety and Depression Scale; LCSS, Lung Cancer Symptom ScaleEQ-5D, EuroQol-5D; EQ-VAS, EuroQol-Visual Analogue Scale; FACT-G, Functional Assessment of Cancer Therapy–General; PTGI, Posttraumatic Growth Inventory; ADL, Katz’s Activities of Daily Living, DT, Distress Thermometer; FACT-Ntx, Functional Assessment of Cancer Therapy/Gynecologic Oncology Group–Neurotoxicity Questionnaire; MDASI-LC, M. D. Anderson Symptom Inventory - Lung Cancer; PHQ-9, Patient Health Questionnaire-9; SF-12, 12-item Short Form Health Survey; SOBQ, The University of California San Diego Shortness of Breath Questionnaire.

Back to article page